(Press-News.org) New York, NY (June 22, 2021) - A new class of drugs that inhibits a "master switch" involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin's lymphoma, has been discovered by researchers at Mount Sinai.
In a study in Clinical Cancer Research published in June, the team reported that the drugs, known as small-molecule inhibitors of the SOX 11 oncogene, are toxic to MCL tumor development in human cells studied outside the body. If the effect is replicated in living patients, the discovery could lead to new therapies for a disease that is highly resistant to existing treatments.
"The SOX 11 protein, which is expressed in up to 90 percent of mantle cell lymphoma patients, is an attractive target for therapy," said senior author Samir Parekh, MD, Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai. "But until now, no small-molecule inhibitor had been identified. We discovered three structurally related compounds which are able to bind to the oncogene, perturb its interaction with DNA and, through their anti-MCL cytotoxicity, actually kill lymphoma cells with remarkable efficiency."
Mantle cell lymphoma represents approximately six percent of all cases of non-Hodgkin's lymphoma, the most common hematological malignancy worldwide. Despite advances in chemotherapy and immunotherapy, MCL patients have a median survival of seven to eight years, and continually relapse after therapies such as ibrutinib, a small-molecule, second-line treatment for the cancer. A major obstacle to the development of compounds that could overcome cellular resistance to treatment has been the fact that SOX 11--a transcription factor that binds to DNA and acts as a master switch to turn genes off and on--is generally considered "undruggable."
To prove otherwise, Dr. Parekh initiated a collaboration with major Mount Sinai research laboratories in Pharmacological Sciences and Oncological Sciences, and the Center for Therapeutics Discovery at Mount Sinai, specializing in structural biology, computer-aided drug discovery, and medicinal chemistry, and led respectively by Aneel Aggarwal, PhD, Marta Filizola, PhD, and Jian Jin, PhD. After screening more than 12 million compounds at the SOX 11 surface that interact with DNA, the team identified a number of small molecules that were predicted to perturb the SOX 11-DNA interaction, thereby blocking the mechanism by which mantle cell lymphoma develops.
Experimental validation confirmed the inhibitory role of three of these molecules. One in particular showed in ex vivo laboratory studies (done on human cells outside the body) anti-MCL cytotoxicity and inhibition of phosphorylation of BTK, which is part of a signaling cascade that triggers the malignant transformation of B lymphocyte cells into mantle cell lymphoma. The Mount Sinai research showed the efficacy of the molecules as single agents, as well as the synergy of ibrutinib in combination with a SOX 11 inhibitor--either of which could potentially represent a therapeutic strategy for treating MCL.
"These small molecule inhibitors could also be useful tools for understanding the pathogenesis of other malignancies that can be traced to SOX 11, including epithelial ovarian tumors, medulloblastoma, gliomas, and basal-like breast cancer," says Dr. Parekh. In a much broader context, he is hopeful that the findings of his team will prompt innovative research by others into transcription factors like SOX 11. "Many transcription factors exist in a variety of tumors that could be targeted by scientists, and what we've demonstrated through our work is that there is indeed an effective way to make them druggable."
INFORMATION:
The Mount Sinai-led study involved collaboration with Ohio State University and the National Institutes of Health. It was funded through a NIH R01 CA252222 grant and a research consortium of major academic institutions focused on accelerating the discovery and development of novel cancer therapeutics and diagnostics. This partnership, funded by Celgene Corporation, includes The Tisch Cancer Institute at Mount Sinai, as well as cancer centers at the University of Pennsylvania, Columbia University, and Johns Hopkins University.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care--from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
CHAPEL HILL, N.C. - Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against COVID-19 but also other coronaviruses and triggered the immune system to fight off a dangerous variant.
While no one knows which virus may cause the next outbreak, coronaviruses remain a threat after causing the SARS outbreak in 2003 and the global COVID-19 pandemic.
To prevent a future coronavirus pandemic, UNC-Chapel Hill researchers designed the vaccine to provide protection from the current SARS-CoV-2 coronavirus and a group of coronaviruses known to make the jump from animals to humans.
The findings were published ...
As many as 16.8 million Americans had undiagnosed SARS-CoV-2 infections - 5 times the rate of diagnosed infections - by the end of July of 2020, according to an analysis of antibodies from more than 8,000 previously undiagnosed adults collected during the pandemic's first wave. The authors calculated that almost 5% of the undiagnosed U.S. population harbored SARS-CoV-2 antibodies, with the highest positivity rates among African Americans, those under the age of 45, urban dwellers, and women. The results suggest a larger spread of COVID-19 in the U.S. than originally suspected in previous reports. SARS-CoV-2 can stealthily cause asymptomatic ...
The rapid development of safe and efficacious vaccines against SARS-CoV-2 has offered hope that the global COVID-19 pandemic may soon be under control. However, vaccinations remain incomplete in many developed nations, and lag further still in the developing world. In a new Focus, Jonathan Sprent and Cecile King posit that vaccine hesitancy, motivated in part by fear of side effects documented in scientific journals and the popular media, could hold back the global population from reaching herd immunity. Seeking to reassure those with reservations, Sprent and King suggest that "it is highly likely ...
Osaka, Japan - As far back as 1959, brewers at Guinness developed a system that fundamentally altered the texture of their draught beer. Now, researchers from Japan have solved the physics of Guinness' cascading flow, which will have widespread applications to technology in life and environmental sciences.
In a study recently published in Physical Review E, researchers from Osaka University have revealed why the nitrogen bubbles of Guinness draught beer flow similarly to a fluid.
The bubbles of many just-opened carbonated beverages simply move upwards, following Archimedes' principle. Much of the appeal of the draught from Guinness beer is that the bubbles sink and flow collectively, known as "bubble cascade." ...
In Finland, every fifth mother was diagnosed with gestational diabetes in 2019. The condition increases the mother's risk of developing type 2 diabetes in the future. However, the most significant consequence of gestational diabetes is fetal macrosomia, or excessive growth of the fetus. Macrosomia increases birth injuries for both the child and the mother, causes fetal hypoxia, that is, a lack of oxygen in the fetus, and increases labour-related complications for the newborn.
A research group active at the University of Helsinki and Helsinki University Hospital demonstrated that the mother's gestational diabetes ...
In a world-first, a Kobe University research group led by Associate Professor FUKAYAMA Hiroshi of the Graduate School of Agricultural Science has used rice to successfully illuminate the mechanism by which plants regulate the amount of starch produced via photosynthesis. This knowledge could contribute towards improving the quality and yield of agricultural crops.
These research results were published in the international scientific journal Plant, Cell & Environment on May 14, 2021.
Main Points
Plants convert carbon dioxide (CO2) into organic substances ...
Without an audience, men run slower and women faster: The lack of spectators during the coronavirus pandemic appears to have had a noticeable effect on the performance of athletes at the 2020 Biathlon World Cup, a new study by Martin Luther University Halle-Wittenberg (MLU) in Psychology of Sport and Exercise shows. According to the new analysis, women also performed better in complex tasks, such as shooting, when an audience was present while men did not.
Social facilitation theory states that a person's performance is impacted if other people watch them. The mere presence of an audience improves the performance of simple tasks, especially those that require stamina. "The studies have been relatively clear so far, but the results are more heterogeneous when it comes to more complex ...
Increased risk of cancer due to a genetic predisposition in first- and second-degree relatives is long-established but has previously only been studied in white or European populations.
Now, a new study published in eLife is the first to demonstrate that the inherited risk of early-onset cancer is significantly higher among Latino and African American families for solid tumors, and Asian/Pacific Islander families for blood-based cancers, compared to non-Latino white families in California.
"Cancer clustering within families, meaning the devastating diagnosis of more than one early-onset cancer within the same family, usually points ...
CORVALLIS, Ore. - Oregon State University research has identified the oldest known specimen of a fungus parasitizing an ant, and the fossil also represents a new fungal genus and species.
"It's a mushroom growing out of a carpenter ant," said OSU's George Poinar Jr., an international expert in using plant and animal life forms preserved in amber to learn about the biology and ecology of the distant past.
A mushroom is the reproductive structure of many fungi, including the ones you find growing in your yard, and Poinar and a collaborator in France named their discovery Allocordyceps baltica. They found the ...
A recent study revealed that as a city becomes more economically developed, its citizens' happiness becomes more directly related to the area of urban green space.
A joint research project by Professor Meeyoung Cha of the School of Computing and her collaborators studied the relationship between green space and citizen happiness by analyzing big data from satellite images of 60 different countries.
Urban green space, including parks, gardens, and riversides not only provides aesthetic pleasure, but also positively affects our health by promoting ...
